Cargando…
Establishment of a retinoic acid-resistant human acute promyelocytic leukaemia (APL) model in human granulocyte-macrophage colony-stimulating factor (hGM-CSF) transgenic severe combined immunodeficiency (SCID) mice.
To understand the mechanisms and identify novel approaches to overcoming retinoic acid (RA) resistance in acute promyelocytic leukaemia (APL), we established the first human RA-resistant APL model in severe combined immunodeficiency (SCID) mice. UF-1 cells, an RA-resistant APL cell line established...
Autores principales: | Fukuchi, Y., Kizaki, M., Kinjo, K., Awaya, N., Muto, A., Ito, M., Kawai, Y., Umezawa, A., Hata, J., Ueyama, Y., Ikeda, Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063129/ https://www.ncbi.nlm.nih.gov/pubmed/9764578 |
Ejemplares similares
-
Treatment of lycorine on SCID mice model with human APL cells
por: Liu, J., et al.
Publicado: (2007) -
Evaluation of hGM-CSF/hTNFα surface-modified prostate cancer therapeutic vaccine in the huPBL-SCID chimeric mouse model
por: Lai, Shouhua, et al.
Publicado: (2015) -
The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein
por: Li, Xiaoqing, et al.
Publicado: (2019) -
Detection and assessment of human tumours producing granulocyte-macrophage colony-stimulating factor (GM-CSF) by heterotransplantation into nude mice.
por: Asano, S., et al.
Publicado: (1980) -
Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)(☆)
por: Holloway, Ryan W., et al.
Publicado: (2018)